Glenmark Pharmaceuticals informs about media release

09 Feb 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release on February 09,2021 titled ‘Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for the Treatment of Adult Patients with COVID-19 in partnership with SaNOtiz’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2010.00 8.95 (0.45%)
28-Jan-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1638.90
Dr. Reddys Lab 1240.05
Cipla 1315.00
Zydus Lifesciences 890.75
Lupin 2147.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×